Immediate Impact
2 from Science/Nature 68 standout
Citing Papers
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Designing antibodies as therapeutics
2022 Standout
Works of Harvey A. Gilbert being referenced
1419TiP ARC-7: A phase II study to evaluate the safety and efficacy of zimberelimab alone, AB154 in combination with zimberelimab, and AB154 in combination with zimberelimab and AB928 in front-line, PD-L1 expressing, non-small cell lung cancer (NSCLC)
2020
Radiation Damage to the Nervous System
1981
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Harvey A. Gilbert | 429 | 181 | 344 | 31 | 701 | |
| Hisayasu Nagakura | 327 | 158 | 233 | 38 | 634 | |
| Brace L. Hintz | 335 | 140 | 307 | 33 | 678 | |
| John A. Vargo | 286 | 272 | 233 | 35 | 646 | |
| A. Reynaud-Bougnoux | 283 | 244 | 328 | 31 | 693 | |
| Ben G. Szabó | 242 | 230 | 242 | 33 | 742 | |
| G.H. Fletcher | 299 | 157 | 220 | 25 | 702 | |
| Samuel S. Kurohara | 285 | 284 | 142 | 53 | 754 | |
| Thongbliew Prempree | 381 | 202 | 247 | 57 | 845 | |
| Michael Tomé | 213 | 138 | 204 | 24 | 607 | |
| Ann M. Chu | 187 | 111 | 210 | 30 | 581 |
All Works
Loading papers...